PhRMA applauds USTR for removing trade preferences

Pharmaceutical Research and Manufacturers of America president Billy Tauzin has praised US Trade Representative Susan Schwab for taking action to remove certain trade privileges under the US Generalized System of Preferences. "Access to the US market for these highly competitive countries under the GSP should be conditional on how well they honor intellectual property rights, among other things. If these governments insist on having poor protection for IPR, they should understand that they may lose some of their trade privileges with the US as a result," he said.